Skip to main content
Download PDF
- Main
PHASE 1B TRIAL OF AVL-292, A COVALENT INHIBITOR OF BRUTON'S TYROSINE KINASE (BTK), IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND B-NON-HODGKIN LYMPHOMA (B-NHL)
- Mahadevan, D;
- Brown, J;
- Harb, W;
- Kelly, K;
- Schreeder, M;
- Sweetenham, J;
- Barr, P;
- Foran, J;
- Gabrilove, J;
- Kipps, T;
- Ma;
- O'Brien, SO;
- Evans, E;
- Lounsbury, H;
- Silver, B;
- Singh, J;
- Stiede, K;
- Westlin, W;
- Witowski, S;
- Sharman, J
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.